VOLITIONRX LTD
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
VNRX$0.18-7.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Deficit
Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited)
| For the Three Months Ended March 31, 2026 and March 31, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Accumulated | |||||||
| Additional · Other · Non - | |||||||
| Common Stock · Paid-in · Comprehensive · Accumulated · Controlling | |||||||
| Shares | Amount | Capital | Income | Deficit | Interest | Total | |
| # | $ | $ | $ | $ | $ | $ | |
| Balance, December 31, 2025 | 6,288,988 | 6,289 | 218,943,759 | (295,071) | (252,901,370) | (1,346,418) | (35,592,811) |
| Common stock issued for cash, net of issuance costs | 1,000,681 | 1,001 | 5,172,803 | - | - | - | 5,173,804 |
| Common stock issued for settlement of RSUs | 25,915 | 26 | (26) | - | - | - | - |
| Issuance of warrants in connection with convertible note offering | - | - | 615,852 | - | - | - | 615,852 |
| Fair value of common stock issued for Convertible note settlement | - | - | 2,803,200 | - | - | - | 2,803,200 |
| Common stock issued for settlement of Convertible note repayments | 615,028 | 615 | (615) | - | - | - | - |
| Stock-based compensation | - | - | 224,982 | - | - | - | 224,982 |
| Tax withholdings paid related to stock-based compensation | - | - | (15,706) | - | - | - | (15,706) |
| Foreign currency translation | - | - | - | 134,307 | - | - | 134,307 |
| Net loss for the period | - | - | - | - | (6,664,774) | (38,783) | (6,703,557) |
| Balance, March 31, 2026 | 7,930,612 | 7,931 | 227,744,249 | (160,764) | (259,566,144) | (1,385,201) | (33,359,929) |
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)
| AccumulatedOther | |||||||
|---|---|---|---|---|---|---|---|
| Additional · Comprehensive · Non - | |||||||
| Common Stock · Paid-in · Income · Accumulated · Controlling | |||||||
| Shares · Amount · Capital · (Loss) · Deficit · Interest | |||||||
| # | $ | $ | $ | $ | $ | Total | |
| Balance, December 31, 2024 | 4,804,874 | 4,805 | 204,246,287 | 385,631 | (229,544,343) | (1,200,116) | (26,107,736) |
| Common stock issued for cash, net of issuance costs | 227,622 | 227 | 2,384,427 | - | - | - | 2,384,654 |
| Common stock issued for settlement of RSUs | 4,878 | 5 | (5) | - | - | - | - |
| Stock-based compensation | - | - | 347,801 | - | - | - | 347,801 |
| Stock-based compensation in relation to modification of options | - | - | 103,573 | - | - | - | 103,573 |
| Tax withholdings paid related to stock-based compensation | - | - | (24,411) | - | - | - | (24,411) |
| Foreign currency translation | - | - | - | (253,929) | - | - | (253,929) |
| Net loss for the period | - | - | - | - | (5,423,759) | (52,868) | (5,476,627) |
| Balance, March 31, 2025 | 5,037,374 | 5,037 | 207,057,672 | 131,702 | (234,968,102) | (1,252,984) | (29,026,675) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.